Nonprofit Linked To PhRMA Rolls Out Campaign To Block Drug Imports
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
The independent source for health policy research, polling, and news.
461-480 of 659 results
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
Some churches and other faith-based organizations are offering clean syringes to IV drug users, while still others are voicing their support for comprehensive treatment, testing and education programs that also help stem transmission of diseases like HIV and hepatitis C.
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
Intense, “high touch” care that focuses on housing as well as health care brings down medical costs for the most expensive patients. But it’s been hard to replicate successful programs.
In a paradox, researchers say testing for a vaccine will depend on the outbreak recurring this year.
Some terminal patients, typically high-dose opioid users, who choose to end their lives have taken many hours, even days, to die.
Poverty and mental illness are among problems keeping about two-thirds of those infected — mainly minorities — from receiving treatment.
After a tough fight by Democrats, Senate Republicans confirmed Rep. Tom Price’s nomination to head the Department of Health and Human Services. He will have the authority to upend some current practices.
Sexually transmitted diseases are at an all-time high across the United States. Syphilis among women and babies is a particularly serious problem in Louisiana, California and Georgia.
Sign-ups for insurance under the Affordable Care Act are still well behind last year’s mark with just a week until the end of open enrollment in most states. The Supreme Court declines a case that could have allowed states to defund Planned Parenthood. And the Trump administration gets hundreds of thousands of comments about its proposed changes to immigration rules that could penalize people who use government-funded health care and other social service programs. Alice Ollstein of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week.
In an interview with Kaiser Health News, Michael Botticelli outlines his concerns about how GOP efforts to dismantle the health law’s coverage expansions could jeopardize treatment for people in need.
Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.
A three-month drug regimen to treat latent TB in a California jail system was just as effective as the standard nine-month approach — and the patients were far more likely to finish treatment.
The move signals growing recognition of HIV/AIDS’ transformation from a death sentence to a serious but manageable disease.
Michael Weinstein of the AIDS Healthcare Foundation says he is promoting condoms where others have forgotten them.
A Kaiser Health News analysis finds that the portion of federal marketplace plans requiring people to pay a third or more of the cost of specialty drugs have jumped from 37 to 63 percent since 2014.
Only 16 percent of the popular plans cover all 10 of the most common drug regimens and charge less than $100 a month in consumer cost sharing, according to a report by Avalere Health.
Despite heavy opposition from the pharmaceutical industry and skepticism from policy experts, many voters see Proposition 61 as a way to protest the nation’s mounting drug prices.
So far this year, more than one in four donations in New England are from people who died after a drug overdose — a much higher rate than in the U.S. overall, though it's not clear why.
Zika virus infection changes both viral and human RNA, affecting the body’s immune response, say researchers at the University of California, San Diego.
© 2026 KFF